Scientists at The University of Nottingham have been searching for polymers on which human pluripotent stem cells can be grown and differentiated in vast numbers - billions at a time.
"The possibilities for regenerative medicine are still being researched in the form of clinical trials. What we are doing here is paving the way for the manufacture of stem cells in large numbers when those therapies are proved to be safe and effective," said Morgan Alexander, Professor of Biomedical Surfaces in the School of Pharmacy.
"The field of regenerative medicine has snowballed in the last five years and over the coming five years a lot more patients will be receiving stem cell treatments," said Chris Denning, Professor of Stem Cell Biology in the School of Medicine.
"Clinical trials are still in the very early stages. However, with this kind of product, if we can get it commercialised and validated by the regulators it could be helping patients in two to three years," Denning said.
